Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07598136 · ClinicalTrials.gov registry record · NA
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
A NA study, sponsored by RAI Services Company.
- Recruiting
- Registry status
- NA
- Development phase
- 1,280
- Enrollment target
NCT07598136: Recruiting NA study, sponsored by RAI Services Company.
NCT07598136 is a NA study that is actively recruiting participants, run by RAI Services Company. The registered enrollment target is 1,280 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07598136, a NA study, is actively recruiting participants, sponsored by RAI Services Company.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,280 participants
- Enrollment target
Study Summary
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, mint, or non-tobacco/non-menthol/non-mint-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Primary Outcome
The estimate of the risk ratio for self-reporting past 7-day abstinence from CC smoking during the final 7 days of the 13-week study period in (i) Study Arm 1 (tobacco and two NTNM flavors) versus Study Arm 3 (tobacco flavor only); and (ii) Study Arm 2 (tobacco, menthol, and mint flavors) versus Study Arm 3.
Interventions
- OTHER P2613422
- OTHER P2611222
- OTHER P2615522
- OTHER P2615122
- OTHER P2615422
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,280 participants |
| Start Date | 2026-05-14 |
| Est. Completion | 2027-01-21 |
| Phase | NA |
What NCT07598136 shows while recruiting
NCT07598136 is an interventional study that assigns participants to a tested intervention. Its 1,280 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which P2613422 is the first listed.
NCT07598136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07598136 about?
NCT07598136 is a clinical study titled "A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers". The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacc...
What is the current status of trial NCT07598136?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,280 participants. The study started on 2026-05-14. Estimated completion is 2027-01-21.
What interventions are being tested in trial NCT07598136?
The interventions under investigation include: P2613422 (OTHER), P2611222 (OTHER), P2615522 (OTHER), P2615122 (OTHER), P2615422 (OTHER).
Who is sponsoring clinical trial NCT07598136?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07598136's enrollment target sits among peer trials
1,280 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI